11
Participants
Start Date
April 28, 2021
Primary Completion Date
July 24, 2025
Study Completion Date
July 24, 2026
Bortezomib
Given SC
Cyclophosphamide
Given IV or PO
Dexamethasone
Given IV or PO
Isatuximab
Given IV
Columbia University, New York
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory University Hospital Midtown, Atlanta
Karmanos Cancer Institute, Detroit
UT Southwestern, Dallas
University of California, Orange
Collaborators (1)
Sanofi
INDUSTRY
National Cancer Institute (NCI)
NIH
Emory University
OTHER